Terms: = Liver cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
15 results:
1. [Evaluation of the Short-Term Efficacy and Safety of Orelabrutinib Combined with High-Dose Methotrexate in the First-line treatment of Elderly Patients with High Risk Primary Central Nervous System Lymphoma].
Xie Y; Qu S; Liao LS; Zheng ZH; Lin Y; Chen WM; Chen BY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1714-1719. PubMed ID: 38071050
[TBL] [Abstract] [Full Text] [Related]
2. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
3. Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma.
Li D; Shi Z; Liu X; Jin S; Chen P; Zhang Y; Chen G; Fan X; Yang J; Lin H
Hepatol Int; 2023 Feb; 17(1):112-130. PubMed ID: 36598701
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of tumour heterogeneity by
Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z
Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895
[TBL] [Abstract] [Full Text] [Related]
5. 16α-18F-fluoro-17β-Fluoroestradiol (fes): Clinical Applications for Patients With Breast cancer.
Ulaner GA
Semin Nucl Med; 2022 Sep; 52(5):574-583. PubMed ID: 35379454
[TBL] [Abstract] [Full Text] [Related]
6. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
Zager RA; Johnson ACM; Therapeutics R
Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
[TBL] [Abstract] [Full Text] [Related]
7. Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study.
Feng J; He Y; Wan J; Chen Z
HPB (Oxford); 2020 Sep; 22(9):1295-1304. PubMed ID: 31892468
[TBL] [Abstract] [Full Text] [Related]
8. Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.
Boers J; Venema CM; de Vries EFJ; Glaudemans AWJM; Kwee TC; Schuuring E; Martens JWM; Elias SG; Hospers GAP; Schröder CP
Eur J Cancer; 2020 Feb; 126():11-20. PubMed ID: 31891878
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical value of (125)I radioactive seed implantation plus transcatheter arterial chemoembolization combined with radiofrequency ablation in treating patient with sub-capsular hepatocellular carcinoma].
Fang SJ; Gao RJ; Zheng LY; Zhao ZW; Fan XX; Song JJ; Zhang DK; Wu FZ; Ji JS
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3853-3857. PubMed ID: 30585029
[No Abstract] [Full Text] [Related]
10. An autopsy case of non-traumatic fat embolism syndrome.
Sakashita M; Sakashita S; Sakata A; Uesugi N; Ishige K; Hyodo I; Noguchi M
Pathol Int; 2017 Sep; 67(9):477-482. PubMed ID: 28667706
[TBL] [Abstract] [Full Text] [Related]
11. Percutaneous liver biopsy: retrospective study of primary and secondary hepatic lymphoma in twenty-one patients.
Bai YF; Liu JM; Zhang XM; Jiang CZ; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):58-64. PubMed ID: 28119260
[TBL] [Abstract] [Full Text] [Related]
12. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
[TBL] [Abstract] [Full Text] [Related]
13. Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and fes-PET as potential significant biomarkers.
Park JH; Kang MJ; Ahn JH; Kim JE; Jung KH; Gong G; Lee HJ; Son BH; Ahn SH; Kim HH; Shin HJ; Moon DH; Kim SB
Cancer Chemother Pharmacol; 2016 Oct; 78(4):685-95. PubMed ID: 27491481
[TBL] [Abstract] [Full Text] [Related]
14. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
[TBL] [Abstract] [Full Text] [Related]
15. Modulation of iron regulatory protein-1 by various metals.
Oshiro S; Nozawa K; Hori M; Zhang C; Hashimoto Y; Kitajima S; Kawamura K
Biochem Biophys Res Commun; 2002 Jan; 290(1):213-8. PubMed ID: 11779155
[TBL] [Abstract] [Full Text] [Related]
